The sex ratio in amyotrophic lateral sclerosis: A population based study.

The sex ratio in amyotrophic lateral sclerosis: A population based study.

Replicable risk factors for ALS include increasing age, family history and being male. The male: female ratio has been reported as being between 1 and 3. We tested the hypothesis that the sex ratio changes with age in a population register covering the south-east of England. The sex ratio before and...

書誌詳細
主要な著者:	Manjaly, Z, Scott, K, Abhinav, K, Wijesekera, L, Ganesalingam, J, Goldstein, L, Janssen, A, Dougherty, A, Willey, E, Stanton, B, Turner, M, Ampong, M, Sakel, M, Orrell, R, Howard, R, Shaw, C, Leigh, P, Al-Chalabi, A
フォーマット:	Journal article
言語:	English
出版事項:	2010

類似資料

The association between ALS and population density: A population based study.
著者:: Scott, K, 等
出版事項: (2010)

Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
著者:: Scott, K, 等
出版事項: (2009)

Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London.
著者:: Johnston, C, 等
出版事項: (2006)

A proposed staging system for amyotrophic lateral sclerosis.
著者:: Roche, J, 等
出版事項: (2012)

Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2002)

Amyotrophic lateral sclerosis
著者:: Leigh P Nigel, 等
出版事項: (2009-02-01)

Evolution of white matter damage in amyotrophic lateral sclerosis
著者:: Gabel, M, 等
出版事項: (2020)

Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2007)

Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.
著者:: Abrahams, S, 等
出版事項: (1997)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
著者:: Balendra, R, 等
出版事項: (2015)

Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
著者:: Balendra, R, 等
出版事項: (2015)

Analysis of terms used for the diagnosis and classification of amyotrophic lateral sclerosis and motor neuron disease
著者:: Rutter-Locher, Z, 等
出版事項: (2016)

REM sleep physiology and selective neuronal vulnerability in amyotrophic lateral sclerosis
著者:: Turner, M, 等
出版事項: (2020)

Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
著者:: Jones, A, 等
出版事項: (2013)

Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
著者:: Balendra, R, 等
出版事項: (2013)

The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis
著者:: Kelly, M, 等
出版事項: (2020)

Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
著者:: Balendra, R, 等
出版事項: (2014)

Biomarkers in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2009)

Large-scale pathways-based association study in amyotrophic lateral sclerosis.
著者:: Kasperaviciute, D, 等
出版事項: (2007)

Large-scale pathways-based association study in amyotrophic lateral sclerosis
著者:: Kasperavičiute, D, 等
出版事項: (2007)

Young-onset amyotrophic lateral sclerosis: Historical and other observations
著者:: Turner, M, 等
出版事項: (2012)

Young-onset amyotrophic lateral sclerosis: historical and other observations.
著者:: Turner, M, 等
出版事項: (2012)

Latent cluster analysis of ALS phenotypes identifies prognostically differing groups.
著者:: Jeban Ganesalingam, 等
出版事項: (2009-09-01)

Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
著者:: Jones, A, 等
出版事項: (2014)

Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis.
著者:: Al-Chalabi, A, 等
出版事項: (2003)

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.
著者:: Fang, F, 等
出版事項: (2013)

Quantifying disease progression in amyotrophic lateral sclerosis.
著者:: Simon, N, 等
出版事項: (2014)

Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2011)

Evolution of white matter damage in amyotrophic lateral sclerosis
著者:: Matt C. Gabel, 等
出版事項: (2020-05-01)

Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
著者:: Wicks, P, 等
出版事項: (2008)

Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
著者:: Wicks, P, 等
出版事項: (2005)

Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: Observational study
著者:: Garcia-Gancedo, L, 等
出版事項: (2019)

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial.
著者:: Morrison, K, 等
出版事項: (2013)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2013)

Comparison of two percutaneous radiological gastrostomy tubes in the nutritional management of ALS patients.
著者:: Rio, A, 等
出版事項: (2005)

Low index-to-ring finger length ratio in sporadic ALS supports prenatally defined motor neuronal vulnerability.
著者:: Vivekananda, U, 等
出版事項: (2011)

Lipid-mediated resolution of inflammation and survival in amyotrophic lateral sclerosis
著者:: Yildiz, O, 等
出版事項: (2025)

Psychiatric disorders prior to amyotrophic lateral sclerosis
著者:: Turner, M, 等
出版事項: (2016)

A multicentre evaluation of oropharyngeal secretion management practices in amyotrophic lateral sclerosis
著者:: McGeachan, AJ, 等
出版事項: (2016)

The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
著者:: R.A.L. Menke, 等
出版事項: (2018-01-01)